Hyperinsulinemia, which occurs in order to compensate for decreased insulin sensitivity, activates the mitogen-activated protein kinase pathway, which leads to increased mitogenic responsiveness to insulin [8]. This evidence concerns the gene INS and Hyperinsulinemia.